Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Nov. 29, 2025	Nov. 30, 2024
Cash flows from operating activities:
Net income	$ 698.2	$ 786.8
Adjustments to reconcile net income to net cash provided by operating activities:
(Gain) loss on property dispositions and impairment losses, net	(28.7)	59.4
Depreciation and amortization	1,439.6	1,396.9
Operating lease right-of-use assets amortization	539.9	522.0
LIFO expense	41.5	22.9
Deferred income tax	(0.4)	(182.9)
Contributions to pension and post-retirement benefit plans, net of expense (income)	(76.6)	(70.7)
Deferred financing costs	15.3	12.4
Equity-based compensation expense	73.6	87.9
Other operating activities	15.5	12.8
Changes in operating assets and liabilities:
Receivables, net	(182.7)	(205.1)
Inventories, net	(549.2)	(214.9)
Accounts payable, accrued salaries and wages and other accrued liabilities	80.6	(77.6)
Operating lease liabilities	(443.0)	(435.1)
Self-insurance assets and liabilities	7.4	35.4
Other operating assets and liabilities	18.6	171.9
Net cash provided by operating activities	1,649.6	1,922.1
Cash flows from investing activities:
Payments for property, equipment and intangibles, including lease buyouts	(1,412.8)	(1,446.7)
Proceeds from sale of assets	85.2	24.1
Other investing activities	42.2	6.1
Net cash used in investing activities	(1,285.4)	(1,416.5)
Cash flows from financing activities:
Proceeds from issuance of long-term debt, including ABL facility	2,585.0	50.0
Payments on long-term borrowings, including ABL facility	(1,350.4)	(250.7)
Payments of obligations under finance leases	(33.1)	(41.1)
Payments for debt financing costs	(33.9)	0.0
Dividends paid on common stock	(246.7)	(208.5)
Treasury stock purchase, at cost	(1,199.7)	0.0
Unsettled accelerated share repurchase agreement	(150.0)	0.0
Employee tax withholding on vesting of restricted stock units	(32.4)	(42.0)
Net cash used in financing activities	(461.2)	(492.3)
Net (decrease) increase in cash and cash equivalents and restricted cash	(97.0)	13.3
Cash and cash equivalents and restricted cash at beginning of period	297.9	193.2
Cash and cash equivalents and restricted cash at end of period	$ 200.9	$ 206.5